Is the Options Market Predicting a Spike in Globe Life Stock? — Neutral
GL Zacks Investment Research — December 17, 2025Investors need to pay close attention to Globe Life stock based on the movements in the options market lately.
A Quiet Day? WBD, Fed Chair Interviews, Earnings Reports — Neutral
WBD Zacks Investment Research — December 17, 2025Between WBD's letter to shareholders, interviews for a new Fed Chair and off-season earnings this morning and afternoon, we've got plenty of grist for the trading mill today.
2 Quantum Stocks I'm Watching Closely for 2026 — Neutral
GOOG IONQ 24/7 Wall Street — December 17, 2025As the new year approaches, it's not hard to imagine that many risk takers are wondering what the next move will be in the fast-paced field of quantum computing.
Gold up, silver soars to record high on safe-haven bids — Positive
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL SIL SILJ SIVR SLV SLVP UGL Kitco — December 17, 2025Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.
Can The Trade Desk's OpenPath Transform the Digital Ad Supply Chain? — Positive
TTD Zacks Investment Research — December 17, 2025TTD is pushing OpenPath as a structural upgrade to digital ads, creating cleaner, direct links to premium publishers as adoption and usage surge.
GSK's Exdensur Gets FDA Nod for Severe Asthma Treatment — Positive
GSK Zacks Investment Research — December 17, 2025GSK secures FDA approval for Exdensur, the first twice-yearly biologic for treating severe asthma with an eosinophilic phenotype.
FEIM Stock Up 29% Despite Q2 Earnings Dip Y/Y on Contract Delays — Negative
FEIM Zacks Investment Research — December 17, 2025Frequency Electronics' fiscal Q2 earnings fall year over year amid earlier contract delays and rising cost pressures despite strong revenue and backlog growth.
New Study Shows Extended-Release Buprenorphine Safely Delivers Rapid, Clinically Meaningful Reductions in Opioid Use and Supports Abstinence in High-Risk Populations — Neutral
INDV PRNewsWire — December 17, 2025Both monthly maintenance doses (100 mg and 300 mg) improved opioid abstinence and were well-tolerated with no new safety signals identified. Post-hoc analyses indicated the 300-mg monthly maintenance dose performed significantly better than the 100-mg monthly dose in participants reporting high-frequency fentanyl use.
Omdia by Informa TechTarget Named Analyst Firm of the Year and Earns Multiple Industry Accolades — Neutral
TTGT Business Wire — December 17, 2025NEWTON, Mass.--(BUSINESS WIRE)--Omdia by Informa TechTarget named Analyst Firm of the year, honored with multiple prestigious awards from industry organizations.
'This is a huge opportunity' to fuel reactors sooner and faster, says Oklo's CEO — Positive
OKLO CNBC Television — December 17, 2025Oklo CEO Jacob DeWitte joins ‘Squawk on the Street' following to discuss turning plutonium stockpiles into energy, Oklo's reactor concept and more.
TWO Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Two Harbors Investment Corp. is Fair to Shareholders — Neutral
TWO Business Wire — December 17, 2025NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Two Harbors Investment Corp. (NYSE: TWO) to UWM Holdings Corporation for 2.3328 shares of UWM Class A Common Stock for each share of Two Harbors common stock is fair to Two Harbors shareholders. Halper Sadeh encourages Two Harbors shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersade.
Janus Henderson Concentrated Growth Managed Account Q3 2025 Portfolio Review — Negative
JHG Seeking Alpha — December 17, 2025Apple's stock faced headwinds earlier in 2025 because of sluggish iPhone sales, weaker consumer spending in China, and uncertainty about tariffs. Marvell has been a beneficiary of increasing demand for data infrastructure – primarily custom silicon – through its relationship with Amazon. Oracle reported strong second-quarter results and exceptional forward guidance, especially for its Oracle Cloud Infrastructure business.
Duke Energy and partners help customers in need stay safe, warm and connected — Neutral
DUK PRNewsWire — December 17, 2025Together with customers, employees and local partners, Duke Energy is making a difference – providing critical energy assistance so families can stay safe and connected during challenging times. CHARLOTTE, N.C.
Micron's Monster 2025 Run Meets Its Biggest Quarter Yet — And The Stock Is Slipping — Neutral
MU Benzinga — December 17, 2025Micron Technology Inc.'s (NASDAQ: MU) stock is sliding into first quarter earnings — not because the AI memory story is cracking, but because expectations have finally caught up. After a 166% year-to-date rally, MU is coming off its highs, down nearly 9% over the past five days, setting up what may be the most consequential quarter of the cycle.
3 Stocks to Consider From the Prospering Consulting Services Industry — Positive
CBZ EXPO FCN Zacks Investment Research — December 17, 2025The Zacks Consulting Services industry is poised to prosper, with service activities remaining healthy. FCN, EXPO and CBZ are three stocks that are well-placed to ride the demand strength.
Can EMCOR Maintain Its 9.1% Margin Streak as Data Centers Explode? — Positive
EME Zacks Investment Research — December 17, 2025EME's improving margin streak is being tested as data center demand reshapes backlog, execution discipline and operating leverage.
Bill Gates, Ken Fisher Rake In $1.7 Billion From Dow Stock That Trounced Nvidia — Positive
NVDA Benzinga — December 17, 2025Bill Gates and Ken Fisher are quietly sitting on massive gains from one of 2025's most overlooked winners. Caterpillar Inc (NYSE: CAT), now the top-performing stock in the Dow, is up more than 62% year-to-date.
Incyte Announces European Commission Approval of Minjuvi® (tafasitamab) for the Treatment of Relapsed or Refractory Follicular Lymphoma — Neutral
INCY Business Wire — December 17, 2025WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY--Incyte Announces European Commission Approval of Minjuvi® (tafasitamab) for the Treatment of Relapsed or Refractory Follicular Lymphoma.
NeuroOne Medical Technologies Corporation (NMTC) Q4 2025 Earnings Call Transcript — Neutral
NMTC Seeking Alpha — December 17, 2025NeuroOne Medical Technologies Corporation (NMTC) Q4 2025 Earnings Call Transcript
UBFO Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of United Security Bancshares is Fair to Shareholders — Neutral
UBFO Business Wire — December 17, 2025NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of United Security Bancshares (NASDAQ: UBFO) to Community West Bancshares for 0.4520 shares of Community West common stock for each share of United Security common stock is fair to United Security shareholders. Halper Sadeh encourages United Security shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or.